1. Home
  2. Stock quotes
  3. Taysha Gene Therapies
  4. Financial Ratios
  5. EV/EBITDA Ratio
Taysha Gene Therapies logo
Taysha Gene Therapies TSHA
$ 2.15 6.72%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Taysha Gene Therapies EV/EBITDA Ratio 2011-2024 | TSHA

Annual EV/EBITDA Ratio Taysha Gene Therapies

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.13 -1.25 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.13 -1.25 -1.19